Views & Analysis ‘Real world’ COPD trial gives GSK a dose of reality Salford Lung Study is a bold experiment, but hasn't fully paid off for GSK.
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
News GSK shows confidence in Brexit Britain with manufacturing in... GSK confident in UK despite Brexit.
Views & Analysis Digital Health Round-up: Pokémon GO, GSK's RA trial & more A round-up of this week’s top digital healthcare news. Marco Ricci reports.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
